Clin2
NCT07797218Possibly a fitRecruiting

Comparing two drug combinations before breast cancer surgery

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Treatments studied

DocetaxelPyrotinibTrastuzumabPertuzumab

Part of Cancer, Skin clinical trials.

This study is comparing two different drug combinations given before breast cancer surgery. The goal is to see which one shrinks tumors more effectively. This type of treatment is called 'neoadjuvant' therapy.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
220 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are a woman between 18 and 70 years old.
  • You have been diagnosed with stage II or III breast cancer that is HER2-positive (a type of protein that helps cancer grow).
  • Your tumor is at least 2 cm in size.
  • You have not had previous cancer treatment, like chemotherapy or radiation.
  • You have no major heart problems.
  • You are able to care for yourself and are not bedridden.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Hear when a new Breast Cancer Early Stage Breast Cancer (Stage 1-3) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.